Quantitative Structure-Activity Relationship (QSAR) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510245274

Publication Date:

October 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

QSAR is a computational modeling method used to determine relationships between structural properties and biological activities of chemical compounds. The drug discovery and development, along with studying the potential therapeutic applications of the drug, is a complicated, expensive, and time-consuming process. Pharmaceutical and biopharmaceutical companies are adopting various computational methodologies such as QSAR to increase the efficiency of this entire process. In stages from hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by various pharmaceutical companies. With the help of modeling, existing data can be leveraged to gain insights into product safety and effectiveness. Owing to the efficiency of computational methods, the Foof and Drug Administration (FDA) and European Medicines Agency (EMA) have incorporated drug modeling to achieve efficient drug development. In addition, in silico (computer-aided) designs are being utilized to expedite and accomplish the process of hit identification; optimize the distribution, absorption, and metabolism of compounds; and draw toxicity profile to avoid safety issues.
The global market for Quantitative Structure-Activity Relationship (QSAR) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Quantitative Structure-Activity Relationship (QSAR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Quantitative Structure-Activity Relationship (QSAR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Quantitative Structure-Activity Relationship (QSAR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Quantitative Structure-Activity Relationship (QSAR) include Protoqsar Sl, Intertek Group Plc, Bibra Toxicology Advice And Consulting Ltd, Covance Inc. (Labcorp), Latham Biopharm Group, Nsf International, Creative Biolabs, Qsar Lab and DassaultSystemes, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Quantitative Structure-Activity Relationship (QSAR), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Quantitative Structure-Activity Relationship (QSAR) by region & country, by Type, and by Application.
The Quantitative Structure-Activity Relationship (QSAR) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quantitative Structure-Activity Relationship (QSAR).
Market Segmentation
By Company
Protoqsar Sl
Intertek Group Plc
Bibra Toxicology Advice And Consulting Ltd
Covance Inc. (Labcorp)
Latham Biopharm Group
Nsf International
Creative Biolabs
Qsar Lab
DassaultSystemes
Segment by Type:
Fragment Based
3D-QSAR
Chemical Descriptor Based
Segment by Application
Pharmaceuticals
Cosmetics
Environmental
Food and Beverages
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Quantitative Structure-Activity Relationship (QSAR) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Quantitative Structure-Activity Relationship (QSAR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Quantitative Structure-Activity Relationship (QSAR) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Quantitative Structure-Activity Relationship (QSAR) Product Introduction
1.2 Global Quantitative Structure-Activity Relationship (QSAR) Market Size Forecast
1.3 Quantitative Structure-Activity Relationship (QSAR) Market Trends & Drivers
1.3.1 Quantitative Structure-Activity Relationship (QSAR) Industry Trends
1.3.2 Quantitative Structure-Activity Relationship (QSAR) Market Drivers & Opportunity
1.3.3 Quantitative Structure-Activity Relationship (QSAR) Market Challenges
1.3.4 Quantitative Structure-Activity Relationship (QSAR) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Quantitative Structure-Activity Relationship (QSAR) Players Revenue Ranking (2023)
2.2 Global Quantitative Structure-Activity Relationship (QSAR) Revenue by Company (2019-2024)
2.3 Key Companies Quantitative Structure-Activity Relationship (QSAR) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Quantitative Structure-Activity Relationship (QSAR) Product Offered
2.5 Key Companies Time to Begin Mass Production of Quantitative Structure-Activity Relationship (QSAR)
2.6 Quantitative Structure-Activity Relationship (QSAR) Market Competitive Analysis
2.6.1 Quantitative Structure-Activity Relationship (QSAR) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Quantitative Structure-Activity Relationship (QSAR) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quantitative Structure-Activity Relationship (QSAR) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fragment Based
3.1.2 3D-QSAR
3.1.3 Chemical Descriptor Based
3.2 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type
3.2.1 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value, by Type (2019-2030)
3.2.3 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceuticals
4.1.2 Cosmetics
4.1.3 Environmental
4.1.4 Food and Beverages
4.1.5 Others
4.2 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application
4.2.1 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value, by Application (2019-2030)
4.2.3 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region
5.1.1 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region (2019-2024)
5.1.3 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region (2025-2030)
5.1.4 Global Quantitative Structure-Activity Relationship (QSAR) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
5.2.2 North America Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
5.3.2 Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
5.4.2 Asia Pacific Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
5.5.2 South America Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
5.6.2 Middle East & Africa Quantitative Structure-Activity Relationship (QSAR) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Quantitative Structure-Activity Relationship (QSAR) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Quantitative Structure-Activity Relationship (QSAR) Sales Value
6.3 United States
6.3.1 United States Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
6.3.2 United States Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
6.4.2 Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
6.5.2 China Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
6.6.2 Japan Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
6.7.2 South Korea Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
6.8.2 Southeast Asia Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Quantitative Structure-Activity Relationship (QSAR) Sales Value, 2019-2030
6.9.2 India Quantitative Structure-Activity Relationship (QSAR) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Quantitative Structure-Activity Relationship (QSAR) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Protoqsar Sl
7.1.1 Protoqsar Sl Profile
7.1.2 Protoqsar Sl Main Business
7.1.3 Protoqsar Sl Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
7.1.4 Protoqsar Sl Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
7.1.5 Protoqsar Sl Recent Developments
7.2 Intertek Group Plc
7.2.1 Intertek Group Plc Profile
7.2.2 Intertek Group Plc Main Business
7.2.3 Intertek Group Plc Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
7.2.4 Intertek Group Plc Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
7.2.5 Intertek Group Plc Recent Developments
7.3 Bibra Toxicology Advice And Consulting Ltd
7.3.1 Bibra Toxicology Advice And Consulting Ltd Profile
7.3.2 Bibra Toxicology Advice And Consulting Ltd Main Business
7.3.3 Bibra Toxicology Advice And Consulting Ltd Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
7.3.4 Bibra Toxicology Advice And Consulting Ltd Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
7.3.5 Covance Inc. (Labcorp) Recent Developments
7.4 Covance Inc. (Labcorp)
7.4.1 Covance Inc. (Labcorp) Profile
7.4.2 Covance Inc. (Labcorp) Main Business
7.4.3 Covance Inc. (Labcorp) Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
7.4.4 Covance Inc. (Labcorp) Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
7.4.5 Covance Inc. (Labcorp) Recent Developments
7.5 Latham Biopharm Group
7.5.1 Latham Biopharm Group Profile
7.5.2 Latham Biopharm Group Main Business
7.5.3 Latham Biopharm Group Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
7.5.4 Latham Biopharm Group Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
7.5.5 Latham Biopharm Group Recent Developments
7.6 Nsf International
7.6.1 Nsf International Profile
7.6.2 Nsf International Main Business
7.6.3 Nsf International Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
7.6.4 Nsf International Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
7.6.5 Nsf International Recent Developments
7.7 Creative Biolabs
7.7.1 Creative Biolabs Profile
7.7.2 Creative Biolabs Main Business
7.7.3 Creative Biolabs Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
7.7.4 Creative Biolabs Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
7.7.5 Creative Biolabs Recent Developments
7.8 Qsar Lab
7.8.1 Qsar Lab Profile
7.8.2 Qsar Lab Main Business
7.8.3 Qsar Lab Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
7.8.4 Qsar Lab Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
7.8.5 Qsar Lab Recent Developments
7.9 DassaultSystemes
7.9.1 DassaultSystemes Profile
7.9.2 DassaultSystemes Main Business
7.9.3 DassaultSystemes Quantitative Structure-Activity Relationship (QSAR) Products, Services and Solutions
7.9.4 DassaultSystemes Quantitative Structure-Activity Relationship (QSAR) Revenue (US$ Million) & (2019-2024)
7.9.5 DassaultSystemes Recent Developments
8 Industry Chain Analysis
8.1 Quantitative Structure-Activity Relationship (QSAR) Industrial Chain
8.2 Quantitative Structure-Activity Relationship (QSAR) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Quantitative Structure-Activity Relationship (QSAR) Sales Model
8.5.2 Sales Channel
8.5.3 Quantitative Structure-Activity Relationship (QSAR) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Protoqsar Sl
Intertek Group Plc
Bibra Toxicology Advice And Consulting Ltd
Covance Inc. (Labcorp)
Latham Biopharm Group
Nsf International
Creative Biolabs
Qsar Lab
DassaultSystemes

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂